Submitted by Anonymous (not verified) on 28 November 2023 - 12:50
Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Stomach Neoplasms, Date of authorisation: 19/12/2014, Revision: 16, Status: Authorised
Source: